SNDX icon

Syndax Pharmaceuticals
SNDX

Overview Fund Activity

163 hedge funds and large institutions have $1.54B invested in Syndax Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 74 increasing their positions, 33 reducing their positions, and 26 closing their positions.

Holders
163
Holders Change
+3
Holders Change %
+1.88%
% of All Funds
2.61%
Holding in Top 10
8
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-27.27%
% of All Funds
0.13%
New
31
Increased
74
Reduced
33
Closed
26
Calls
$1.97M
Puts
$3.49M
Net Calls
-$1.52M
Net Calls Change
-$1.72M

Top Buyers

1
Morgan Stanley
1
Morgan Stanley
New York
$23.1M
2
BI
2
BVF Inc
California
$45.3M
3
KCM
3
Kynam Capital Management
New Jersey
$67.7M
4
EP
4
Eversept Partners
New York
$46.7M
5
BlackRock
5
BlackRock
New York
$104M

Top Sellers

1
APM
1
Avidity Partners Management
Texas
$81.6M
2
Wellington Management Group
2
Wellington Management Group
Massachusetts
$148M
3
DTC
3
Deep Track Capital
Connecticut
$0
4
ITP
4
Iron Triangle Partners
Connecticut
$0
5
GCM
5
Ghisallo Capital Management
Massachusetts
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Wellington Management Group
1
Wellington Management Group
Massachusetts
$148M 7,003,734 -979,708 -12%
BlackRock
2
BlackRock
New York
$104M 4,900,841 +548,809 +13%
State Street
3
State Street
Massachusetts
$81.7M 3,866,230 +217,767 +6%
APM
4
Avidity Partners Management
Texas
$81.6M 3,865,300 -1,995,700 -34%
FLSM
5
Frazier Life Sciences Management
California
$78.3M 3,708,838 – –
Vanguard Group
6
Vanguard Group
Pennsylvania
$73.9M 3,497,085 +133,635 +4%
KCM
7
Kynam Capital Management
New Jersey
$67.7M 3,205,986 +644,799 +25%
ACA
8
Avoro Capital Advisors
New York
$56M 2,650,000 – –
Jennison Associates
9
Jennison Associates
New York
$51M 2,416,454 +114,208 +5%
PBA
10
Paradigm Biocapital Advisors
New York
$48M 2,274,512 +320,000 +16%
EP
11
Eversept Partners
New York
$46.7M 2,209,057 +588,344 +36%
BI
12
BVF Inc
California
$45.3M 2,143,197 +692,000 +48%
PHS
13
PFM Health Sciences
California
$41.1M 1,946,652 +132,018 +7%
O
14
OrbiMed
New York
$36.2M 1,711,675 -294,825 -15%
Citadel Advisors
15
Citadel Advisors
Florida
$33.4M 1,579,669 -48,184 -3%
Dimensional Fund Advisors
16
Dimensional Fund Advisors
Texas
$27.9M 1,320,225 +54,096 +4%
Geode Capital Management
17
Geode Capital Management
Massachusetts
$25.9M 1,227,601 +126,572 +11%
Morgan Stanley
18
Morgan Stanley
New York
$23.1M 1,093,844 +944,475 +632%
SI
19
Sofinnova Investments
California
$22.7M 1,075,424 +372,350 +53%
ACM
20
Aisling Capital Management
New York
$21.6M 1,025,000 – –
T. Rowe Price Investment Management
21
T. Rowe Price Investment Management
Maryland
$21.1M 1,000,715 -2,171 -0.2%
Barclays
22
Barclays
United Kingdom
$20.7M 981,886 +18,550 +2%
NCM
23
Nantahala Capital Management
Connecticut
$20.6M 975,705 – –
B
24
Braidwell
Connecticut
$19.4M 920,049 -322,753 -26%
FCMI
25
Foresite Capital Management IV
California
$18.5M 875,000 – –
1
2 3 4 5